EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients

Elin Dahlén iD, Carola Bardage, Paulina Tuvendal, Rickard Ljung

International Journal of Methods in Psychiatric Research · 2024-03 · 33 (1)

DOI: 10.1002/mpr.1998 ↗

At a glance

Journal article in International Journal of Methods in Psychiatric Research, published online on 2024-02-13. Written by Elin Dahlén and 3 co-authors. Institution: The Swedish Medical Products Agency, Uppsala, Sweden. Major MEDLINE topics: Anti-Anxiety Agents. Cited 7 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

Anxiety and sleep disorders are common in the population and anxiolytics and sedatives are widely used. Our aim was to describe the drug utilization of new users of anxiolytics and sedatives in adults including type of drug, doses, prescribers' characteristics, and psychiatric comorbidity.

Methods

A register‐based cohort study of new users (18–64 years) of anxiolytics and sedatives in 2015–2019, free of any such drug 5 years prior to inclusion. The individuals were linked to national registers on dispensed drugs and recorded diagnoses.

Results

In total, 764,432 new users of anxiolytics and sedatives were identified, which corresponds to an incidence of 26/1000 inhabitants and year. The proportion of new users of benzodiazepines (including both anxiolytics and sedatives) decreased, whereas the proportion of sedative antihistamines and melatonin increased. The most common drug dispensed was hydroxizin (33%) followed by benzodiazepine related drugs (zopiclone and zolpidem; 20%), propiomazine (14%) and benzodiazepines (13%). The majority (68%) of the prescriptions were from primary care. Most new users were prescribed 1–30DDDs and 52% among women and 49% among men were dispensed their drug only once during the first year. Half of the new users had a previous comorbid psychiatric disorder.

Conclusions

The findings are well reflecting the recommendations in national guidelines.

Subjects

MeSH terms (MEDLINE)

Anti-Anxiety AgentsMaleAdultHumansFemaleHypnotics and SedativesSwedenCohort StudiesBenzodiazepinesComorbidityDrug Prescriptions

Author keywords

anxietybenzodiazepinesincidencenew userssedatives

Substances

Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepines

Authors and institutions

  • The Swedish Medical Products Agency, Uppsala, Sweden.
  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID profiles: Elin Dahlén

Cite

APA

Dahlén, E., Bardage, C., Tuvendal, P., & Ljung, R. (2024). New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients. International Journal of Methods in Psychiatric Research, 33(1). https://doi.org/10.1002/mpr.1998

Vancouver

Dahlén E, Bardage C, Tuvendal P, Ljung R. New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients. International Journal of Methods in Psychiatric Research. 2024;33(1). doi:10.1002/mpr.1998

BibTeX
@article{Dahln2024,
  author = {Dahlén, Elin and Bardage, Carola and Tuvendal, Paulina and Ljung, Rickard},
  title = {New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients},
  journal = {International Journal of Methods in Psychiatric Research},
  year = {2024},
  volume = {33},
  number = {1},
  doi = {10.1002/mpr.1998}
}
Start for free →